Platelet-activating factor acetylhydrolase is not associated with carotid intima-media thickness in

Salvatore Campo1, Maria A Sardo, Alessandra Bitto

  • 1Department of Internal Medicine and Institute of Statistical Science, School of Medicine, University of Messina, Messina, Italy.

Clinical Chemistry
|September 15, 2004
PubMed

Insights

Platelet-activating factor acetylhydrolase (PAF-AH) gene variants do not appear to influence PAF-AH activity or atherosclerosis in hypercholesterolemic individuals. This study found no significant differences in PAF-AH polymorphisms related to carotid artery intima-media thickness.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Biology
  • Biochemistry

Background:

  • Atherosclerosis is a complex chronic disease influenced by factors like hypertension, hyperlipidemia, and oxidized LDL.
  • Platelet-activating factor acetylhydrolase (PAF-AH) is an enzyme that hydrolyzes PAF and prevents LDL oxidation, potentially delaying atherosclerosis.

Purpose of the Study:

  • To investigate the association between specific PAF-AH gene polymorphisms (Arg92His, Ile198Thr, Ala379Val) and carotid atherosclerosis.
  • To determine if these polymorphisms affect PAF-AH activity and intima-media thickness in hypercholesterolemic individuals.

Main Methods:

  • Studied 190 hypercholesterolemic Sicilian individuals.
  • Measured carotid artery intima-media wall thickness (IMT) as an indicator of atherosclerosis.
  • Analyzed PAF-AH gene polymorphisms, PAF-AH activity, and various clinical and biochemical parameters.

Main Results:

  • A significant correlation was found between PAF-AH activity and LDL concentrations in hypercholesterolemic patients.
  • No significant differences in PAF-AH gene polymorphisms were detected between groups with normal and abnormal IMT after adjusting for confounding factors.
  • Plasma PAF-AH activity did not significantly correlate with HDL levels in either IMT group.

Conclusions:

  • The study found no evidence that the investigated PAF-AH gene polymorphisms influence PAF-AH activity or the presence of atherosclerosis.
  • These findings suggest that PAF-AH polymorphisms may not be significant determinants of atherosclerosis in this hypercholesterolemic population.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...